BRIEF published on 04/30/2025 at 18:05, 1 year 1 month ago Neovacs fundraising: a 0.25 million euro operation Biotechnology Fundraising Shareholder Dilution Néovacs OCEANE-BSA
BRIEF published on 04/30/2025 at 18:05, 1 year 1 month ago Levée de fonds de Néovacs : une opération de 0,25 million d'euros Biotechnologie Levée De Fonds Néovacs OCEANE-BSA Dilution Actionnaire
PRESS RELEASE published on 04/30/2025 at 18:00, 1 year 1 month ago Levée de fonds de 0,25 MEUR Néovacs annonce levée fonds 0,25M€ par émission d'OCEANE-BSA pour financer recherche allergies et investir en Biotech/Medtech. Détails communiqués Biotech MedTech Levée De Fonds Néovacs OCEANE-BSA
BRIEF published on 04/17/2025 at 18:35, 1 year 2 months ago Fundraising of 0.25 Million Euros by Neovacs Fundraising Shareholder Dilution Biotech Néovacs OCEANE-BSA
BRIEF published on 04/17/2025 at 18:35, 1 year 2 months ago Levée de Fonds de 0,25 Million d'Euros par Néovacs Biotech Levée De Fonds Néovacs OCEANE-BSA Dilution Actionnaire
PRESS RELEASE published on 04/17/2025 at 18:30, 1 year 2 months ago Levée de fonds de 0,25 M EUR Néovacs annonce une levée de fonds de 0,25 M€ par l'émission d'OCEANE-BSA destinée au développement de la recherche Kinoïde® sur les allergies et à l'investissement dans des projets prometteurs en BioTech et MedTech Biotech MedTech Levée De Fonds Néovacs OCEANE-BSA
BRIEF published on 04/16/2025 at 08:05, 1 year 2 months ago Neovacs Addresses Rumors About PXT3003 Biopharmaceuticals Market Authorization PXT3003 Tasly Charcot-Marie-Tooth
BRIEF published on 04/16/2025 at 08:05, 1 year 2 months ago Néovacs s'exprime sur les rumeurs concernant le PXT3003 Biopharmaceutique PXT3003 Tasly Charcot-Marie-Tooth Autorisation Marché
PRESS RELEASE published on 04/16/2025 at 08:00, 1 year 2 months ago Néovacs fait le point sur des rumeurs Néovacs fait le point sur les rumeurs concernant l'autorisation de mise sur le marché de PXT3003 en Chine et l'impact potentiel sur ses actifs. Aucune confirmation disponible pour le moment Autorisation De Mise Sur Le Marché Néovacs PXT3003 Impact Potentiel Procédure De Liquidation
BRIEF published on 04/02/2025 at 20:05, 1 year 2 months ago Adjustment of the nominal value of Neovacs shares Shareholders Capital Reduction Dilutive Financing Nominal Value Néovacs
Published on 06/26/2026 at 01:40, 8 hours ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/25/2026 at 23:30, 10 hours 10 minutes ago Zeus North America Mining Corp. Signs Option Agreement to Acquire Mining Claims in Idaho
Published on 06/25/2026 at 22:30, 11 hours 10 minutes ago Fountain Asset Corp. Provides Corporate Update
Published on 06/25/2026 at 21:32, 12 hours 8 minutes ago BlackBerry Announces Election Results for the Company's Board of Directors
Published on 06/25/2026 at 15:30, 18 hours 10 minutes ago Silver Spruce Resources, Inc. Adds Mining, Energy, and Finance Development Expertise to the Board and Announces Director Resignation
Published on 06/26/2026 at 09:26, 14 minutes ago Hamburg Direct Bank wins two German Brand Awards 2026
Published on 06/26/2026 at 09:25, 14 minutes ago SKYWORTH Solar Shines at Intersolar Europe 2026, Shaping the Future of Energy in Europe with a Comprehensive Product Matrix
Published on 06/26/2026 at 09:19, 20 minutes ago Zero Waste Foundation brought Türkiye’s COP31 vision to Bonn
Published on 06/26/2026 at 09:05, 34 minutes ago Avinox Wins Eurobike 2026 Award with its Smart Heart Rate Control System
Published on 06/26/2026 at 09:02, 37 minutes ago Kirchhoff Consult and DSW publish 2026 forecast report study: Number of transparent forecast reports in the DAX 40 rises
Published on 06/26/2026 at 07:00, 2 hours 40 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 2 hours 40 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 14 hours 54 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 15 hours 10 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
Published on 06/25/2026 at 17:50, 15 hours 50 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
